![]() |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Categories list
AlcoholismAlzheimer's And Parkinson'sAnalgesicsAnti-inflammatoriesAntiallergicAntibioticsAnticonvulsantsAntidepressantsAntifungalsAntiparasiticAntiviralsArthritisAsthmaBirth ControlCancerCardiovascular DiseasesCholesterolDiabetesDiureticsErectile DysfunctionEye CareGastrointestinal TractH I VHypertensionMen's HealthMental DisordersMigraineMuscle RelaxantsNeurological DisordersObesityOsteoporosisRespiratory TractSkin CareSurgeryUrinary TractWomen's Health 09 May 2012 04:22:05
XOMA's CEO Discusses Q1 2012 Results - Earnings Call TranscriptXOMA's CEO Discusses Q1 2012 Results - Earnings Call Transcript Seeking Alpha Commercially, the three primary wholesalers are set up for electronic ordering and have place orders for ACEON . All of the ACEON that was started by Abbott is now depleted and all ACEON that is being shipped has XOMA's logo on the boxes and package ...
08 May 2012 22:06:41
XOMA Reports Financial Results for First Quarter 2012 and Highlights Recent ...XOMA Reports Financial Results for First Quarter 2012 and Highlights Recent ... MarketWatch (press release) On January 17, XOMA announced the launch of its commercial operations through the acquisition of US development and commercialization rights to ACEON (R) (perindopril erbumine) and a portfolio of fixed-dose combination product candidates incorporating a ...
25 Apr 2012 14:11:47
Dr. Rubin Promoted to the Newly Created Position of Senior Vice President ...Dr. Rubin Promoted to the Newly Created Position of Senior Vice President ... PharmaLive (press release) (subscription) To implement this strategy, the Company established its US commercial operations through the acquisition of US rights to Servier's ACEON Â (perindopril erbumine), a marketed angiotensin converting enzyme (ACE) inhibitor. The agreement with Servier ...
24 Apr 2012 22:32:40
Photo Release -- XOMA Integrates Research, Preclinical and Clinical ...Photo Release -- XOMA Integrates Research, Preclinical and Clinical ... MarketWatch (press release) To implement this strategy, the Company established its US commercial operations through the acquisition of US rights to Servier's ACEON (R) (perindopril erbumine), a marketed angiotensin converting enzyme (ACE) inhibitor. The agreement with Servier ...
|
|
Choose Your language:
Site search:
Testimonials
The parcel has arrived today, thanks for your prompt delivery. The extra pack enclosed to the order is greatly appreciated. - Best regards, U Geilert
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Bestsellers|Policies|Frequently Asked Questions|Testimonials|Contact us|Sitemap |
|
|
|
|
| |